TA Associates completed fundraising for its latest flagship fund, TA XV, with total limited partner commitments at its hard cap of $16.5 billion.
Launched in late November 2022, TA XV was oversubscribed and exceeded its initial target size. As with its predecessor equity funds, TA XV will target equity investments in high-quality businesses capable of delivering sustainable growth, including healthcare. Read more.
